Back to search

Poland· PL-100423944

Lisinopril/Amlodipine Holsten

A lisinopril und amlodipin product containing lisinoprilum + amlodipinum, registered in Poland by Holsten Pharma GmbH. The same ATC class is registered in 4 of our 19 countries.

ATC C09BB03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLisinopril/Amlodipine HolstenATCC09BB03REGISTER NO.PL-100423944PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Lisinopril und amlodipin is registered in 4 of 19 countries.

Countries holding a registration under ATC C09BB03 (lisinopril und amlodipin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose

Lisinopril und amlodipin · ATC C09BB03

4 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Lisinoprilum + Amlodipinum
Manufacturer
Holsten Pharma GmbH
Country
Poland (PL)
ATC code
C09BB03
ATC class
Lisinopril und Amlodipin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909991474324
  • gtin
    05909991474331
  • gtin
    05909991474348
  • gtin
    05909991474355

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

17 interactions on record for lisinopril und amlodipin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lisinopril und amlodipin · interactions on record

17 records

17 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Lisinopril und amlodipin in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lisinopril und amlodipin products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Lisam
  • Bulgaria · Диронорм, Скоприл Комбо
  • Czechia · Amesos
  • Estonia · Dironorm
  • Spain · Lisonorm
  • Croatia · Skopryl Combo
  • Hungary · Lisidipin, Lisinopril/Amlodipine Alkaloid-Int
  • Lithuania · Dironorm
  • Latvia · Dironorm
  • Malta · Lisinopril/Amlodipine Alkaloid-Int
  • Portugal · Lisinopril + Amlodipina Alkaloid-Int, Lisinopril + Amlodipina Zentiva
  • Slovenia · Skopryl Combo
  • Slovakia · Dironorm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fbd99da9-040e-4fd8-8c05-6eeac6b86cf3
GET /v1/drugs/fbd99da9-040e-4fd8-8c05-6eeac6b86cf3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "20 mg + 5 mg",
  "packaging": "05909991474324 ¦ Rp ¦ 143344\n20 tabl.\n05909991474331 ¦ Rp ¦ 143345\n30 tabl.\n05909991474348 ¦ Rp ¦ 143346\n60 tabl.\n05909991474355 ¦ Rp ¦ 143347\n90 tabl.",
  "substance": "Lisinoprilum 20 mg + Amlodipinum 5 mg",
  "common_name": "Lisinoprilum + Amlodipinum",
  "pl_product_id": "100423944",
  "pozwolenie_nr": "26853",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

See everything about lisinopril und amlodipin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.